118 related articles for article (PubMed ID: 34821169)
21. CD34, CD117, and actin expression in phyllodes tumor of the breast.
Chen CM; Chen CJ; Chang CL; Shyu JS; Hsieh HF; Harn HJ
J Surg Res; 2000 Dec; 94(2):84-91. PubMed ID: 11104647
[TBL] [Abstract][Full Text] [Related]
22. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
23. Anal phyllodes tumor in a male patient: a unique case presentation and literature review.
Ho SP; Tseng HH; King TM; Chow PC
Diagn Pathol; 2013 Mar; 8():49. PubMed ID: 23531415
[TBL] [Abstract][Full Text] [Related]
24. Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.
Muller KE; Tafe LJ; de Abreu FB; Peterson JD; Wells WA; Barth RJ; Marotti JD
Hum Pathol; 2015 Feb; 46(2):327-33. PubMed ID: 25476122
[TBL] [Abstract][Full Text] [Related]
25. [The important morphological parameters used to differentiate benign/malignant phyllodes tumors of the breast].
Küçük Ü; Pala EE; Bayol Ü; Erdoğan IG
Turk Patoloji Derg; 2012; 28(3):245-50. PubMed ID: 23011827
[TBL] [Abstract][Full Text] [Related]
26. Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.
Rooper LM; Huang SC; Antonescu CR; Westra WH; Bishop JA
Hum Pathol; 2016 Sep; 55():44-50. PubMed ID: 27137987
[TBL] [Abstract][Full Text] [Related]
27. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
28. Management of a periductal stromal tumor in a young woman: Our breast unit experience.
Valente I; Ristani A; Mancini C; Martella E; Quartieri L; D'Aloia C
Breast J; 2020 Jul; 26(7):1375-1378. PubMed ID: 32297694
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
[TBL] [Abstract][Full Text] [Related]
30. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
[TBL] [Abstract][Full Text] [Related]
31. Lipophyllodes of the breast. A reappraisal of fat-rich tumors of the breast based on 22 cases integrated by immunohistochemical study, molecular pathology insights, and clinical follow-up.
Bacchi CE; Wludarski SC; Lamovec J; Ben Dor D; Ober E; Salviato T; Zanconati F; De Maglio G; Pizzolitto S; Sioletic S; Falconieri G
Ann Diagn Pathol; 2016 Apr; 21():1-6. PubMed ID: 27040923
[TBL] [Abstract][Full Text] [Related]
32. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
Chen PH; Bossuyt V; Reisenbichler E
Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
[TBL] [Abstract][Full Text] [Related]
33. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
34. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
35. [Periductal stromal tumor of the breast. A case report].
Chavet X; Van Eeckhout P; Ska S; Blaude M; Moreaux O; Feoli F
J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):503-6. PubMed ID: 20547011
[TBL] [Abstract][Full Text] [Related]
36. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
37. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
38. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
[TBL] [Abstract][Full Text] [Related]
39. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
40. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
